Concurrent stereotactic radiation with antibody-drug conjugates in the treatment of brain metastases is associated with a greater risk of symptomatic radiation necrosis
1. A greater percentage of patients who received concurrent stereotactic radiation therapy with antibody-drug conjugates manifested severe levels of radiation ...